EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Piperlongumine attenuates knee osteoarthritis progression by eliminating senescent meniscus cells and chondrocytes

Kentaro Endo, Nobutake Ozeki, Hideyuki Koga, Ichiro Sekiya

Biochemical and Biophysical Research Communications · 2026-09 · 829 · 154179

DOI: 10.1016/j.bbrc.2026.154179 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-09. Verfasst von Kentaro Endo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Stem Cell and Regenerative Medicine, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan. Electronic address: en…. Hauptthemen laut MEDLINE: Dioxolanes, Cellular Senescence, Chondrocytes, Osteoarthritis, Knee. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, Takeda Science Foundation, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Cellular senescence in cartilage is a driver of knee osteoarthritis (OA) progression, but its role in the meniscus remains unclear. This study investigated whether senescent cells accumulate in both meniscus and cartilage during OA, aiming to identify senolytic drugs for their selective elimination. METHODS: Senescence and senescence-associated secretory phenotype (SASP) marker expression was assessed in meniscus and cartilage of OA-induced rats. Rat meniscus cells (MCs) and chondrocytes (CCs) were rendered senescent with H2O2 and treated with candidate senolytics, including piperlongumine (PL). Transcriptomic analysis was performed to explore the PL mechanism. PL effects were also tested in OA patient-derived MCs and CCs. Finally, PL was administered to OA rats to evaluate its effect on OA progression. RESULTS: Senescence markers (p16, p21) and SASP factors (MMP3, MMP9, MMP13, MCP1) were upregulated in the OA rat meniscus and cartilage. PL outperformed other senolytics, selectively eliminating senescent MCs and CCs without harming normal cells. Transcriptomic analysis revealed that PL altered reactive oxygen species (ROS)-related pathways specifically in senescent cells, while cotreatment with ROS scavengers completely blocked PL-induced cell death. In human OA MCs and CCs, PL reduced senescent cell numbers and enhanced glycosaminoglycan production. In OA rats, PL treatment alleviated meniscus and cartilage degeneration, decreased senescence and SASP marker expression, and suppressed synovitis. CONCLUSION: This study provides the first direct evidence of meniscal senescence in OA and demonstrates that PL can selectively clear senescent MCs and CCs, attenuating OA progression. These findings highlight the strong potential of PL as a disease-modifying OA drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DioxolanesCellular SenescenceChondrocytesOsteoarthritis, KneeMeniscusAnimalsPiperidonesHumansRatsDisease ProgressionRats, Sprague-DawleyReactive Oxygen SpeciesMaleCells, CulturedSenescence-Associated Secretory Phenotype

Stichwörter der Autor:innen

CartilageCellular senescenceMeniscusOsteoarthritisPiperlongumine

Substanzen

DioxolanespiperlonguminePiperidonesReactive Oxygen Species

Autor:innen und Institutionen

  • Center for Stem Cell and Regenerative Medicine, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan. Electronic address: endo.arm@tmd.ac.jp.
  • Center for Stem Cell and Regenerative Medicine, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan. Electronic address: ozeki.arm@tmd.ac.jp.
  • Department of Joint Surgery and Sports Medicine, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan. Electronic address: koga.orj@tmd.ac.jp.
  • Center for Stem Cell and Regenerative Medicine, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan. Electronic address: sekiya.arm@tmd.ac.jp.

Förderung

  • Japan Agency for Medical Research and Development
  • Takeda Science Foundation
  • Japan Society for the Promotion of Science

Zitieren

APA

Endo, K., Ozeki, N., Koga, H., & Sekiya, I. (2026). Piperlongumine attenuates knee osteoarthritis progression by eliminating senescent meniscus cells and chondrocytes. Biochemical and Biophysical Research Communications, 829, 154179. https://doi.org/10.1016/j.bbrc.2026.154179

Vancouver

Endo K, Ozeki N, Koga H, Sekiya I. Piperlongumine attenuates knee osteoarthritis progression by eliminating senescent meniscus cells and chondrocytes. Biochemical and Biophysical Research Communications. 2026;829:154179. doi:10.1016/j.bbrc.2026.154179

BibTeX
@article{Endo2026,
  author = {Endo, Kentaro and Ozeki, Nobutake and Koga, Hideyuki and Sekiya, Ichiro},
  title = {Piperlongumine attenuates knee osteoarthritis progression by eliminating senescent meniscus cells and chondrocytes},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {829},
  pages = {154179},
  doi = {10.1016/j.bbrc.2026.154179}
}
Kostenlos starten →